MAPT and Alzheimer disease: Conversely, transgenic Tg2576 AD model mice with reduced SOD2 activity, and therefore increased oxidative stress, have been shown to exhibit increased amyloid burden [83,84] and increased tau hyperphosphorylation [84,85], both of which are major hallmarks of AD.